论文部分内容阅读
BACKGROUND AND PURPOSE:It has been demonstrated that centrally antihypertensive action of moxonidine is resulted from activation of Imidazoline-1 receptor (I1R) in the rostral ventrolateral medulla (RVLM).Increased superoxide in the RVLM contributes to high level of blood pressure and sympathetic outflow in hypertension.